In hepatocellular carcinoma, blocking STAT3 activity using the STAT3 ODN-decoy led to the inhibition of proliferation and cell cycle progression of HepG2, PLC/PRF/5, and H7402 cells [174]. Here, STAT3 is linked to hepatocellular carcinoma.